drugset / Trial / NCT01015729
Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to investigate whether a fixed dose combination (FDC) capsule of esomeprazole 20 mg and acetylsalicylic acid (ASA) 81 mg has equivalent therapeutic efficacy compared to each of 2 free combinations of ASA tablet 81 mg plus esomeprazole 20 mg in patients at risk of gastrointestinal events using low dose ASA for cardiovascular protection.
Timeline
- Start
- 2009-11
- Primary completion
- —
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetylsalicylic Acid | Unknown | 81 mg | Oral |
| Comparator | Acetylsalicylic Acid | Unknown | 325 mg | Oral |
| Comparator | Esomeprazole | Small molecule | 20 mg | Oral |